Security key
05464T104
Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 37,169,613
- Share change
- -696,727
- Total reported value
- $4,513,412,476
- Put/Call ratio
- 98%
- Price per share
- $121.45
- Number of holders
- 352
- Value change
- -$67,590,005
- Number of buys
- 189
- Number of sells
- 141
Report period
Q3 2025
Institutions
352
Top holders
10
AXSM full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Axsome Therapeutics, Inc. SEC filings
Axsome Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05464T104
Recent filing periods:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
|
Company |
3.1%
|
1,516,903
|
$165,312,089 | -$153,206,917 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
3,945,020
|
$411,820,637 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.8%
|
3,834,990
|
$400,334,606 | — | 30 Jun 2025 | |
| BVF INC/IL |
13F
|
Company |
3.5%
|
1,690,221
|
$176,442,170 | — | 30 Jun 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.3%
|
1,137,748
|
$118,770,000 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
989,453
|
$103,302,818 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
2%
|
976,730
|
$101,960,869 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
958,503
|
$100,058,128 | — | 30 Jun 2025 | |
| Fairmount Funds Management LLC |
13F
|
Company |
1.7%
|
815,176
|
$85,096,223 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.6%
|
801,371
|
$83,655,119 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.5%
|
753,429
|
$78,650,453 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
725,672
|
$75,749,589 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
725,044
|
$75,687,343 | — | 30 Jun 2025 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
667,368
|
$69,666,546 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
612,743
|
$63,966,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
595,455
|
$62,159,547 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
571,549
|
$59,664,000 | — | 30 Jun 2025 | |
| Man Group plc |
13F
|
Company |
1.1%
|
525,069
|
$54,811,953 | — | 30 Jun 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.99%
|
483,105
|
$50,431,331 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
0.96%
|
468,329
|
$48,888,864 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
447,919
|
$46,758,325 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.91%
|
447,000
|
$46,662,330 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.87%
|
427,900
|
$44,668,481 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.84%
|
411,850
|
$42,993,022 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
409,394
|
$42,736,639 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.8%
|
391,617
|
$40,880,899 | — | 30 Jun 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.76%
|
371,104
|
$38,739,547 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
356,651
|
$37,230,798 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.73%
|
355,511
|
$37,111,793 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.72%
|
350,973
|
$36,638,098 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.68%
|
331,131
|
$34,566,765 | — | 30 Jun 2025 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.67%
|
326,318
|
$34,064,336 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.58%
|
282,971
|
$29,539,343 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.57%
|
278,510
|
$29,073,658 | — | 30 Jun 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.57%
|
277,465
|
$28,964,572 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.51%
|
248,726
|
$25,965,000 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
228,204
|
$23,822,216 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.46%
|
224,721
|
$23,458,625 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
223,280
|
$23,308,199 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.42%
|
203,632
|
$21,257,100 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.41%
|
200,764
|
$20,957,754 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.41%
|
198,534
|
$20,724,964 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.38%
|
187,728
|
$19,596,926 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.38%
|
186,437
|
$19,462,158 | — | 30 Jun 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.38%
|
184,164
|
$19,224,880 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.37%
|
180,960
|
$18,890,414 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.33%
|
163,000
|
$17,015,570 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.33%
|
161,412
|
$16,849,799 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.33%
|
159,233
|
$16,622,295 | — | 30 Jun 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.32%
|
157,861
|
$16,479,110 | — | 30 Jun 2025 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q3 2025
As of 30 Sep 2025,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
352 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,169,613 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, MACQUARIE GROUP LTD, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., STATE STREET CORP, and FMR LLC.
This page lists
353
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
345
Q3 2025 holders
352
Holder diff
7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.